🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in Turkey / NCT07496203
Recruiting Not applicable

The Effectiveness of BETY in Knee Osteoarthritis With Intra-Articular Injections

NCT07496203 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-01-02
Last updated
2026-03-27

Condition(s) studied

Osteo Arthritis of the KneePainPain ManagementExercise

Investigational drug(s) / intervention(s)

BETY

BETY: Participants in this group will follow a traditional exercise program consisting of active range-of-motion exercises for the knee joint, isometric muscle strengthening, and stretching exercises targeting the lower extremity muscle groups.

Study summary

Osteoarthritis (OA) is the most common condition in middle-aged and elderly populations; it causes pain and physical disability and is characterized by cartilage degeneration, changes in bone tissue, inflammation of the synovial membrane, and an increased inflammatory response. Because pain and depression often co-occur in individuals diagnosed with OA, the concepts of disability and health-related quality of life caused by the disease have become more decisive than radiological joint damage. The chronic nature of the disease, like other chronic conditions, encompasses a range of biopsychosocial impacts, including pain, fatigue, sleep disturbances, functional loss, anxiety, depression, and social isolation. This complex structure is accompanied by a pattern in which inflammatory processes are triggered. Recently, intra-articular injections (such as Platelet-Rich Plasma Therapy (PRP), Hyaluronic Acid (HA), PRP+HA combinations, Corticosteroids, Prolotherapy, and Stem Cells) have been accepted as a treatment for OA. Regarding the mechanism of these intra-articular injections, it has been reported that a combination of various anabolic and anti-inflammatory cytokines may treat inflammation associated with the early stages of OA. It has been demonstrated that, through the effects of various growth factors, these treatments have a positive impact on chondrogenesis and mesenchymal stem cell proliferation by increasing anti-inflammatory mediators and reducing pro-inflammatory mediators.

Bilişsel Egzersiz Terapi Yaklaşımı - BETY (Cognitive Exercise Therapy Approach in english) is an exercise approach based on the biopsychosocial model. BETY consists of innovations in function-oriented body stabilization exercises (FoGSE), chronic pain management (BETY-Nociplastic Pain Management (BETY-NPM)), emotion-mood information management (dance therapy-authentic movement), and sexuality information management. The aim of this study is to investigate the effectiveness of BETY, which is often initiated following intra-articular injections-a treatment frequently chosen for individuals diagnosed with knee osteoarthritis (OA).

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Diagnosis of knee osteoarthritis according to ACR knee osteoarthritis diagnostic criteria * Being in stage 2 or 3 according to Kellgren-Lawrence radiological staging criteria * having received an intra-articular injection in the knee within the past month * To be 18 years of age or older * Being a reader-writer * Having read and signed the informed consent Exclusion Criteria: * History of major psychiatric illness * Having malignant disease * Having chronic infectious or other rheumatologic diseases * Serious knee trauma or surgical operation in the last 6 months * Having collagen tissue disease * History of peripheral vascular disease or neuropathy * Being in stage 4 according to Kellgren Lawrence radiologic staging criteria * To have received a physiotherapy program for the relevant knee in the last 3 months

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Hacettepe University Ankara Samanpazarı Recruiting

More Hacettepe University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07496203 on ClinicalTrials.gov ↗ ← All trials in Turkey